Search research articles
Contact Us
Filters
Showing results (181-190 of 196) with videos related to
Page
of 20
Sort By:
Virchows Archiv : an International Journal of Pathology
|
May 21, 2026
Clinicopathologic characterization of renal tumors with Folliculin (FLCN) biallelic inactivation
Stephanie E Siegmund, Sara E Wobker, Lara R Harik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor
Tom Zhang, Christopher A Febres-Aldana, Zebing Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2020
Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor
Koichi Ogura, Romel Somwar, Julija Hmeljak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 14, 2023
Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification
Arielle Elkrief, Igor Odintsov, Vladimir Markov, et al.
Cancer Discovery
|
June 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway
Pietro Scaparone, Alessia Mira, Taek-Chin Cheong, et al.
Disease Models & Mechanisms
|
December 15, 2020
RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation
Takuo Hayashi, Igor Odintsov, Roger S Smith, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 22, 2025
Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers With Different MET Exon 14 Skipping Mutations
Federica Pecci, Prashasti Agrawal, Jessica S Ross, et al.
Cancer Discovery
|
February 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy
Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov, et al.
Cancer Discovery
|
February 9, 2022
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements
Alison M Schram, Igor Odintsov, Madelyn Espinosa-Cotton, et al.
Disease Models & Mechanisms
|
November 29, 2021
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
Roger S Smith, Igor Odintsov, Zebing Liu, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 196) with videos related to
Sort By:
Page
of 20
Virchows Archiv : an International Journal of Pathology
|
May 21, 2026
Clinicopathologic characterization of renal tumors with Folliculin (FLCN) biallelic inactivation
Stephanie E Siegmund, Sara E Wobker, Lara R Harik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor
Tom Zhang, Christopher A Febres-Aldana, Zebing Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2020
Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor
Koichi Ogura, Romel Somwar, Julija Hmeljak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 14, 2023
Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification
Arielle Elkrief, Igor Odintsov, Vladimir Markov, et al.
Cancer Discovery
|
June 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway
Pietro Scaparone, Alessia Mira, Taek-Chin Cheong, et al.
Disease Models & Mechanisms
|
December 15, 2020
RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation
Takuo Hayashi, Igor Odintsov, Roger S Smith, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 22, 2025
Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers With Different MET Exon 14 Skipping Mutations
Federica Pecci, Prashasti Agrawal, Jessica S Ross, et al.
Cancer Discovery
|
February 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy
Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov, et al.
Cancer Discovery
|
February 9, 2022
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements
Alison M Schram, Igor Odintsov, Madelyn Espinosa-Cotton, et al.
Disease Models & Mechanisms
|
November 29, 2021
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
Roger S Smith, Igor Odintsov, Zebing Liu, et al.
Page
of 20